Antiseptics and Disinfectants Market Report Up to 2031: Visiongain Research Inc
December 28, 2021 10:24 ET
|
Visiongain Ltd
Visiongain has published a new report on Antihypertensives Market Report to 2031. Market is segmented by type (Diuretics, Beta-blockers, ACE inhibitors, Angiotensin II receptor blockers, calcium...
Apixaban Market Research Report Up to 2031: Visiongain Research Inc
December 23, 2021 09:30 ET
|
Visiongain Ltd
Visiongain has published a new report on Apixaban Market Report to 2031. Market is segmented By Dosage Form (Capsule, Tablet), By end user (Hospitals, Retail Pharmacies, Online Pharmacies, Others)....
Autoimmune Disease Therapeutics Market Report Up to 2031: Visiongain Research Inc
December 23, 2021 09:00 ET
|
Visiongain Ltd
Visiongain has published a new report on Autoimmune Disease Therapeutics Market Report to 2031. Market is segmented By Indication (Rheumatic Disease, Multiple Sclerosis, Diabetes, Inflammatory Bowel...
Multiple Sclerosis Drugs Market Report Up to 2031: Visiongain Research Inc
December 21, 2021 09:30 ET
|
Visiongain Ltd
Visiongain has published a new report on Multiple Sclerosis Drugs Market Report 2021-2031:Forecasts By Drug Class (Corticosteroids, Interferon Beta, Sphingosine 1 Phosphate Receptor Modulators, Mixed...
Bacterial Conjunctivitis Market Research Report Up to 2031: Visiongain Research Inc
December 15, 2021 09:30 ET
|
Visiongain Ltd
Visiongain has published a new report on Bacterial Conjunctivitis Market Report to 2031. Profiles of Leading Bacterial Conjunctivitis Market players, Regional and Leading National Market Analysis....
Oral Contraceptive Pills Market Report Up to 2031: Visiongain Research Inc
December 08, 2021 09:30 ET
|
Visiongain Ltd
Visiongain has published a new report on Oral Contraceptive Pills Market Report 2021-2031: Forecasts By Type (Combination, Progestin Only, and Others), By Age (15-19, 20-29, 30-39, and 40-49), By Drug...
Acromegaly Treatment Market Report to 2031: Visiongain Research Inc.
July 29, 2021 10:00 ET
|
Visiongain Ltd
Visiongain has published a new report on Acromegaly Treatment Market Report to 2031: Forecasts By Disease Type (Ectopic Acromegaly and Pseudo Acromegaly), By Drug Class (Somatostatin Analogs (SSAs)...
Global Asthma & Copd Market set to grow to $47bn by 2024, according to Visiongain report.
March 29, 2019 13:01 ET
|
Visiongain Ltd
London, UK, March 29, 2019 (GLOBE NEWSWIRE) -- The asthma and COPD market benefits from increasing prevalence of respiratory diseases, coupled with the high economic cost of those diseases. The...
Visiongain states that "Translational regenerative medicine market set to grow to $76bn by 2023".
March 28, 2019 06:16 ET
|
Visiongain Ltd
London, UK, March 28, 2019 (GLOBE NEWSWIRE) -- The high potential earning for companies from products aimed at repairing organs and tissues has led to an increase in the attention given to...
Visiongain report says: “30% of the top generic drug producers are in the row region”.
March 22, 2019 06:00 ET
|
Visiongain Ltd
London, UK, March 22, 2019 (GLOBE NEWSWIRE) -- This report ranks the world’s top 50 generic drug manufacturers according to their generic drug revenues in 2017. It analyses the leading companies...